Figure 2.
Figure 2. CORAL study results. PFS of patients in CORAL study according to prior exposure to rituximab. Patients receiving rituximab as part of induction therapy had inferior outcome. Reproduced with permission from the Journal of Clinical Oncology.32

CORAL study results. PFS of patients in CORAL study according to prior exposure to rituximab. Patients receiving rituximab as part of induction therapy had inferior outcome. Reproduced with permission from the Journal of Clinical Oncology.32 

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal